Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-020241

President & COO sold 100,000 shares at $10.95 ($1,095,000)

  • President & COO gave up 39,148 shares (to pay taxes)
  • President & COO acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & COO 2025-05-20 Shares withheld for taxes 10b5-1 −39,148 $11.04 $432,194 1,077,197 D: show line 1 in the form
Venker Eric President & COO 2025-05-20 Option exercise 10b5-1 +100,000 $3.85 $385,000 1,177,197 D: show line 2 in the form
Venker Eric President & COO 2025-05-20 Sale 10b5-1 −100,000 $10.95 $1,095,000 1,077,197 D: show line 3 in the form
Open-market sales · 100,000 sh · avg $10.95 · $1,095,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Venker Eric President & COO 2025-05-20 Option exercise · Stock Option (Right to Buy) 10b5-1 −100,000 9,723,923 D: show line 4 in the form
Loading xslF345X05/form4.xml…